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Abstract 
Objective: To determine whether patients with acute unilateral peripheral vestibulopathy (PVP), often 
called “vestibular neuritis/neuronitis or neuropathy” (VN) have a vestibular lesion pattern consistent 
with the distribution of the neurological afferents. 
Background: Much is known about the clinical nature of PVP, however less so about its etiology and 
pathogenesis. Due to the frequency in which VN is used to describe the syndrome, an inflammation of 
the vestibular nerve or of one of its branches is often assumed to be the cause of PVP, though there is 
insufficient data so far to support this assumption. 
Methods: We conducted a retrospective study of 25 patients who had presented to our clinic with PVP 
and had tested all vestibular receptor organs shortly after start of symptoms. We analysed their vestibu-
lar lesion patterns in order to determine whether they were consistent with the neuritis hypothesis (NH). 
Results: The lesion patterns varied conspicuously, 76% did not abide by the innervation pattern to the 
NH and only 24% did having either definite (16%) or probable (8%) VN. 
Conclusion: These results should remind us to be careful before jumping to quick conclusions about the 
pathogenetic nature of PVP. With any reason to question VN as the only cause of PVP, we should re-
consider the treatment approach to PVP. If the cause probably or even possibly lies inside the vestibular 
labyrinth, an intratympanic steroid injection might prove to be a more effective measure, even in first-
line treatment. If the etiology is unsure, a combination of systemic and intratympanic steroid treatment 
may be adequate. 
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Introduction 
The symptoms of an acute vestibular syndrome are well described in the literature. They are 
mainly due to a unilateral peripheral vestibulopathy (PVP), if central lesions are excluded are 
most commonly named vestibular neuritis, neuronitis or neuropathy- for a short historical review 
see Reker [34].  Since there are no formal diagnostic criteria there is some variation in the defini-
tion, which poses a challenge when trying to compare studies from different authors or clinics[3, 
37]. PVP manifests itself in the acute onset of spinning vertigo lasting many hours or several 
days, often accompanied by nausea and vomiting[14, 20]. The patients usually present with gait 
instability[14] and a falling tendency toward the affected side. The clinician normally detects a 
horizontal nystagmus beating toward the healthy side obeying Alexander’s law. Caloric and head 
impulse testing show hypofunction of the horizontal semicircular canal (hSCC)[37]. The fre-
quently occurring ocular tilt reaction[22] toward the affected side which can be observed directly 
through fundoscopy or be inferred from testing the subjective visual vertical (SVV)[24] is in-
dicative of an utricular hypofunction as is an asymmetry ratio (AR) in ocular vestibular evoked 
myogenic potentials (oVEMPs). The saccular afferents from the vestibular organ as tested 
through cervical VEMPs frequently remain unaffected[14], but can also be dysfunctional[30, 
45]. The frequent sparing of the sacculus previously led to the conclusion that vestibular neuritis 
chiefly affects the superior vestibular nerve whilst sparing its inferior half in most cases[14]. 
Another explanation for these findings calls attention to the fact that patients who only have pa-
thologies in their posterior SCC (pSCC) and/or sacculus are less likely to be diagnosed as having 
PVP due to the absence of a spontaneous nystagmus (SPN) or pathological caloric test 
results[21, 26]. 
At the time the etiological hypothesis of superior / inferior / total vestibular neuritis (henceforth: 
neuritis hypothesis, NH) was proposed it was reasonable to assume that the dysfunction in PVP 
follows a neuroanatomical pattern, since most routine testing included only one receptor per 
nerve branch (caloric for hSCC i.e. superior vestibular nerve, cVEMP for sacculus i.e. inferior 
vestibular nerve). However, such assumptions need to be re-evaluated in the advent of new diag-
nostic methods that might offer new insights into the pathogenesis of PVP. For about a decade, it 
has now been possible to assess both utricular and saccular function in clinical practice using 
oVEMP (introduced in 2007[35]) and cVEMP (introduced in 1992[35]). The video head impulse 
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test (vHIT), introduced for hSCC testing  in 2009[5, 28] and for vertical SCC testing in 
2013[27], which serves as an alternative to the more expensive, time-consuming and more dis-
comforting magnetic search-coil HIT, first described for testing all SCC in 1998[10] allows for a 
quick assessment of all SCC receptors separately. Given the availability of these new precise 
methods it is sensible to test the NH against all receptors, that is, if the NH is true, PVP should 
either show a hypofunction of all receptors of the superior vestibular nerve, all receptors of the 
inferior vestibular nerve or both. In other words, the lesion pattern of the vestibular receptors in 
PVP should be the same as the innervation pattern of the vestibular organ. 
To our knowledge an analysis of the lesion patterns in PVP with the aim of testing the NH has 
not been performed so far. The goal of our study was to map the lesion patterns of our PVP pa-
tients in order to test whether they are the same as the innervation patterns. 
In a retrospective study was according to the declaration of Helsinki and approved by the local 
ethics committee, we analysed the lesion patterns of the patients who had presented and been 
treated for PVP in our clinic over the last years. 
Etiology and pathogenesis of PVP: The evidence so far 
The research on the etiology and pathogenesis of PVP is variegated. There are many 
contradictory findings, some of which support the NH while others do not or even contradict it. 
The many terms – vestibular neuritis / neuronitis / neuropathy / neuronopathy, acute 
vestibulopathy, acute vestibular neurolabyrinthitis, acute labyrinthitis1 – often used 
interchangeably to describe PVP, testify to the fact that there is still much to be discovered about 
the nature of the disease.A less disputed issue is the fact that PVP is often preceded by a viral 
infection of the upper respiratory tract[37] or the higher prevalence (compared to controls) of 
Herpes viruses in the eighth and other cranial nerves and their neurons[1, 12, 17, 41] as well as 
in the saliva of patients with PVP[33]. One animal study also supports the etiopathogenetic role 
of Herpes viruses, but points to histopathological changes in both the vestibular nerve and 
labyrinth[13]. HSV-1 has also be detected in the labyrinth [2]  
                                                 
1 This term is misleading, because it is usually used to describe a combined vestibulo-cochlear deficit. (Baloh, Clini-
cal Practice 2003) 
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The anatomical evidence of a vestibulo-facial nerve anastomosis is one way of explaining the 
presence of those viruses in the vestibular neurons.[32] However, the prevalence as described in 
those studies is insufficient to support Herpes viruses as the only etiological factor. More likely 
those findings point to the fact that PVP may have a multifactorial etiology. Alternatively they 
raise the question whether PVP might be, rather than a single pathological entity, a catch-all bas-
ket for a group of diseases with similar symptoms that do not match another known diagnostic 
entity. 
Often the case for the NH is made by presenting PVP as analogous to Bell’s palsy, which is also 
thought to be caused by a reactivation of viruses that subsequently leads to a nerve oedema and a 
loss of function[2, 15]. However reasonable this analogy may seem, there are two important dif-
ferences: Firstly, corticosteroids have been found to be reasonably effective in the treatment of 
Bell’s palsy[15], while their effect in treating PVP is less established [16, 43]. This might be 
suggestive of a distinctive pathogenetic mechanism rather than a similarity. Secondly, while the 
Bell’s palsy analogy is a justified model to consider, other equally plausible analogies should 
also be taken into account. This includes, for instance, Herpes labialis, in which the reactivation 
of viruses – often proposed as a possible pathomechanism in PVP – leads to pathological chang-
es in the sensory end organ (skin). This analogy would support a pathogenetic model with in-
tralabyrinthic changes, rather than an isolated neuritis. 
Other evidence cited in favour of the NH includes MRI studies and histopathological analyses. 
There is one MRI double case report that mentions changes on the vestibular nerve (but not in 
the labyrinth) in two patients, 7 and 11 days after symptom onset, respectively[25]. Besides be-
ing a case report, findings made many days after the first symptoms need to be considered with 
much care. Moreover, this study contradicts two othersthat looked at MRI’s of 8 and 60 patients 
with PVP, respectively and found no signs of a neuritis[23, 40]. Histopathological studies have 
found that there was evidence of viral infections and subsequent loss of neurons in the vestibular 
nerve. However, they also found significant changes in the labyrinth: There was a kind of “epi-
thelialization” on the otolith maculae as well as in the cristae of the SCC[4]. An animal study 
confirms the evidence of a viral infection on both the vestibular nerve and labyrinth[13]. 
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The fact that benign paroxysmal positional vertigo (BPPV) is more prevalent in patients with a 
history of PVP also supports a pathogenetic model with the involvement of an inthralabyrinthine 
lesion (some 20% of patients with a history of PVP will develop BPPV in their lifetime[20]). 
As a whole, these findings do not strongly support the NH. It would therefore at least be prudent 
to consider the involvement of the vestibular labyrinth in the pathogenesis of PVP.  
The main goal of this study is to determine how many of the patients with PVP present with an 
intralabyrintine lesion pattern. In other words: In what part of patients is the vestibular lesion 
pattern at odds with the vestibular innervation anatomy? 
 6 
Materials and Methods 
The patient database of our clinic was searched for patients aged 18-80 who had presented be-
tween January 2006 and April 2014 and for whom a diagnosis of PVP was considered due to 
their clinical symptoms (n=202). After applying the exclusion criteria, 25 patients qualified for 
our study. 
Exclusion criteria were as follows (see also figure 1): patients with a different final diagnosis 
(n=60, 7 Menière or migraine; 42 with additional hearing loss, thus labyrinthitis; 11 with ves-
tibular schwannoma), patients on whom relevant diagnostic tests were not performed within 10 
days of symptom onset and within a maximum of 3 days after the beginning of treatment with 
corticosteroids (n=117). There were no patients in this sample with vertigo of central cause, who 
we would also have excluded from our study. 
We included only patients who had tests performed on all their SCC receptors and the utricle. 
There were 8 patients without cVEMP’s, thus without saccular diagnostics. 
Our approach to classifying patients as having PVP is one of a diagnosis of exclusion[39]. This 
means we included all patients with prolonged acute vertigo and nystagmus without hearing loss, 
for whom no other diagnosis or more likely cause was found. 
In order to understand whether receptors with equal innervations were similarly affected – which 
would support the NH – we introduced a scale of 4 different dysfunction levels (DL) for each 
receptor (see table 1). Those levels are to be understood as follows: 0 = no dysfunction, 1 = 
slight dysfunction or possible false positive, 2 = definite dysfunction, 3 = strong dysfunction or 
total loss of function. 
The dysfunction levels for the vertical SCC’s were calculated on the basis of their respective HIT 
gains. If for a specific receptor there were clear corrective saccades despite the presence of a 
normal gain (3 cases, i.e. covert saccades), they were classified as strongly dysfunctional. The 
DL of the hSCC was calculated from either the HIT alone or the average of HIT, DVA and ca-
loric CP, in case those latter tests had been performed. The DL’s for the utricle were similarly 
calculated by using either one or an average of the test results from the SVV[42], the ocular tor-
sion (OT)[9, 11] and oVEMP. Finally, the saccular DL was calculated on the basis of 
cVEMP’s[36, 44]. 
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We then classified the patients according to whether their lesion pattern supported the NH (i.e. 
the lesion pattern was the same as the innervation pattern), using a second set of groups (see also 
fig. 2 and 3 for examples): definite neuritis-like pattern (NP, see also figure 2), likely NP, likely 
ILP (inthralabyrinthine lesion pattern), definite ILP (table 2, see also figure 3). Strictly speaking, 
the occurrence of an ILP in a patient would contradict the NH. An inthralabyrinthine lesion 
though, could theoretically present as a NP, which is why the occasional occurrence of a NP does 
not, by itself, condradict the inthralabyrinthine lesion thesis. Therefore, if the NH is true, we 
would expect an overwhelming majority of the patients to present with a NP, allowing for the 
few remaining cases to be explained as measurement errors. 
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Results 
Among our 25 patients 19 (76%) had a lesion pattern that looked more like an ILP than a NP 
(see figure 4). 9 of those had a definite ILP, while another 10 likely do not fit the NH. Only 6 
patients (24%) had a NP, potentially supporting the NH, 4 (16%) of which had a definite NP, the 
remaining 2 a likely NP. Roughly half of the patients with a definite ILP had major dysfunction 
differences in the receptors of the superior vestibular nerve, the other half had dysfunction dif-
ferences in the receptors of the inferior vestibular nerve (see table 3). 
 
Inter-method-validity of diagnostic methods for the same vestibular receptor 
In order to validly use different measurement methods for the same receptor, it is important that 
those measurements deliver similar results. Below are the numbers of inter-measurement-
discrepancies for the different methods to assess the hSCC and utricular function. Two meas-
urements for the same receptor were seen as significantly discrepant when the resulting DL 
scores differed by more than 1 DL point. 
hSCC 
In 2 out of 23 cases where more than the HIT was performed those tests significantly differed 
from one another (by more than 1 DL point). 
Utricle 
In 3 out of 15 cases where more than one test for the utricle was performed those results signifi-
cantly differed from one another (twice by 2 DL points, once by 3 DL points). 
All in all, when more than one method was used to assess a receptor function in our study popu-
lation, it can be said that these methods lead to fairly similar results, meaning that they were suf-
ficiently conclusive to draw further conclusions from them. 
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Discussion 
The results of our study do not support the NH since about 3/4 our patients had an intralabyrin-
thine lesion pattern inconsistent with an isolated nerve lesion. 
Our study does not prove that the only location there can be a lesion causing PVP is the vestibu-
lar labyrinth, neither does it reject the NH altogether. However, our results do suggest that there 
could be other loci affected by PVP in addition to the vestibular nerve. 
Another model to consider is that PVP consists of a combined vestibular neuro-labyrinthitis spar-
ing the cochlea. This theory would account for the tendency among certain patients to present 
with a NP while the ILP found in the others can be explained by an intralabyrinthine inflamma-
tion that does not follow the innervation pattern. 
Consequently, it raises the question whether systemic corticosteroids are the best approach to 
treat PVP. It is well documented, that even high-dosage i.v. corticosteroids only barely reach the 
perilymph at very low concentrations, while intratympanic delivery would be much more effec-
tive[6-8, 31], not to mention the reduction of systemic adverse effects. And meta-analyses as 
well as recent studies do not yet show a clear evidence for efficacy of systemic steroid 
treatment[16, 18, 19].  In sudden sensorineural hearing loss, where a neuritis is rarely assumed to 
be the cause, intratympanic corticosteroid application is widely accepted for salvage treatment 
with sufficient evidence in several studies including meta-analyses[38]. 
Furthermore, an intralabyrinthic lesion theory would give a more appealing explanation as to 
why patients with a history of PVP are more likely to suffer from BPPV: It is conceivable that an 
inflammation of the utricle may cause otoliths to dissociate from the receptor, while the NH fails 
to address this issue. 
A recent study by Magliulo et al.[29] looked at 1-year follow-up results of UVD patients in their 
oVEMP, cVEMP and vHIT measurements showing acute-phase findings similar to ours: Half of 
their patients had incomplete involvement of vestibular receptors of their superior and/or inferior 
vestibular nerve. However, the authors remained true to the NH and argue for the existence of 
even more subgroups of vestibular neuritis than the two (three) described so far, superior and 
inferior vestibular neuritis (or the combination thereof). However, applying the principle of par-
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simony it might be more accurate to consider an intralabyrinthic lesion as a possible cause of 
PVP. 
Limitations 
There are several limitations to our study, the main ones being the small sample size and the ret-
rospective study design. 
Other criticism may concern to the introduction of our classification system of vestibular recep-
tor dysfunction with four different DL’s. We think though that the use of such semi-quantifiable 
values is justifiable: The idea of introducing DL’s was developed to apply enough spacing be-
tween a normal vestibular receptor function and a clear dysfunction in order to judge whether the 
patient’s lesion pattern is in accordance with the NH or not. 
Another limitation is the use of different receptor function measurements in dependence of their 
availability for each patient. Since our investigation was of qualitative rather than quantitative 
nature, we think that this does not inflict on the conclusions of our study. However, this certainly 
is an issue, which we would address in a prospective study design. 
Another criticism that might emerge is that neuritis does not need to affect all receptors similarly. 
In light of other known neuritic lesions of cranial nerves that lead to a more or less homogenous 
dysfunction of the affected sensory or motor organ (i.e. Bell’s Palsy, optic neuritis, oculomotor 
neuritis), such criticism does not strike us as justified. 
 
Conclusions 
To our knowledge, this is the first study to address the issue of lesion patterns in patients with 
PVP by using tests of all 5 vestibular receptors aiming at proving or disproving the neuritis hy-
pothesis. Our findings, although limited due to the study design and small sample size, indicate 
that it might be premature to assume that all PVP is caused by neuritis. Further research into le-
sion patterns in PVP is needed to clarify this issue.  
If our suspicion – that a significant part of PVP patients (if not all of them) has an intralabyrin-
thine lesion or inflammation – is true, it may have important implications on the treatment ap-
proach to PVP. Since even high dose i.v. corticosteroids are known to insufficiently penetrate the 
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blood-labyrinth barrier, administration of intratympanic steroids could be a more effective choice 
to treat affected vestibular endorgan lesions. In case of individually not clearly defined lesions a 
combination of systemic and intratympanic treatment could be an alternative approach with 
maybe lower doses of systemic steroids. 
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